1.79
0.04 (2.29%)
AISkor Stockmoo
| Nilai 30% | -1.0 |
| Pulangan di bawah kos modalnya. Pulangan atas modal meningkat. info | |
| Daripada penilaian laporan AI Insight kami tentang pulangan dijangka berbanding risiko. info | NA |
| Penilaian Relatif info | NA |
| Pertumbuhan Tersirat info | NA |
| Sejarah Penilaian info | NA |
| Kesihatan Kewangan info | NA |
| Trend Perolehan info | NA |
| Nilai Pegangan info | NA |
| Premium Risiko info | NA |
| Penilaian Pasaran info | NA |
| Masa 30% | -4.0 |
| Aliran menurun sepanjang tahun lalu. Jauh di bawah paras tertinggi 52 minggu. info | |
| Aliran menurun: harga di bawah purata bergeraknya, dan purata itu sedang menurun. Harga hampir dengan purata itu. Dagangan lebih tinggi pada hari harga naik. info | |
| Daripada analisis teknikal AI kami terhadap carta. info | NA |
| Corak Lilin info | NA |
| Sentimen 20% | 0.0 |
| Tiada harga sasaran terkini, jadi berdasarkan arah semakan harga sasaran. info | |
| Sentimen Pegangan info | NA |
| Sentimen Berita info | NA |
| Wang Pintar 20% | -1.1 |
| Institusi bersih -0.58% daripada saham dalam pemfailan 13F terkini: 3 pemegang menambah, 2 mengurang (suku berakhir 30 Sep 2026). info | |
| Kedudukan jual singkat +21.3% dari 31 Aug hingga 30 Oct 2026, 1 hari untuk tutup (FINRA). info | |
| Aktiviti Orang Dalam info | NA |
| Keadaan pasaran dan sektor lemah. | |
| Persekitaran pasaran berhati-hati. info | |
| Sektor ketinggalan berbanding pasaran. | |
| Tonggak-tonggak sependapat, jadi skor diperkukuh. | |
| Tidak dikira dalam skor | |
| Di bawah garis aliran jangka sederhana. info | |
| Harga rendah berbanding purata 52 minggunya. Turun dalam tempoh 5 tahun. info | |
| Momentum jangka pendek menurun. info | |
| Paras sokongan dan rintangan menaik. info | |
| Skor Akhir | -2.43 |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Agricultural Inputs (US) | Bercampur | Bercampur |
| Agricultural Inputs (Global) | Bercampur | Bercampur | |
| Stok | Nexentis Technologies Inc. | - | - |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B | Skor |
|---|---|---|---|---|---|
| NXTS | - | - | - | 0.280 | -2.4 |
| LVRO | 35 M | - | - | - | -1.6 |
| SEED | 9 M | - | - | - | -4.3 |
| NITO | 3 M | - | - | - | 0.0 |
| BIOX | 11 M | - | - | 0.370 | -4.6 |
|
Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology. |
|
| Sektor | Basic Materials |
| Industri | Agricultural Inputs |
| Gaya Pelaburan | Small Value |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Institusi
Pemilikan institusi: 1.62%
| Kedudukan | Pemegang | Saham |
|---|---|---|
| Bertambah | 3 | 6,225 |
| Berkurang | 2 | 9,178 |
| Baharu | 3 | 6,225 |
| Dijual habis | 1 | 9,048 |
Pemfailan SEC 13F melalui Nasdaq, pemfailan terkini hingga 30 Sep 2026. Pemfailan tiba sehingga 45 hari selepas setiap suku.
Kedudukan Jual Singkat
| Penyelesaian | Saham | Hari untuk tutup |
|---|---|---|
| 30 Oct 2026 | 63,636 | 1.0 |
| 15 Oct 2026 | 61,274 | 1.0 |
| 30 Sep 2026 | 37,720 | 1.0 |
| 15 Sep 2026 | 39,461 | 2.3 |
| 31 Aug 2026 | 52,477 | 1.7 |
| 14 Aug 2026 | 62,682 | 1.1 |
Data jual singkat FINRA melalui Nasdaq, dilaporkan dua kali sebulan.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 17 Nov 2026 | Yahoo Finance |
Nexentis: MitoCareX Progresses Toward In-Vitro Evaluation Following AI-Powered Computational Screening
Further computational prioritization by MitoCareX leads to selection and ordering of molecules for planned experimental assessment Ness Ziona, Israel, , Nov. 17, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (NASDAQ: NXTS) (“Nexentis” or the “Company”) today announced that its wholly owned… |
| 05 Nov 2026 | Yahoo Finance |
Nexentis Announces Reverse Stock Split
Ness Ziona, Israel, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (NASDAQ: NXTS) (“Nexentis” or the “Company”), a drug discovery company that also invests in solar energy assets based on the RTB (Ready to Build) business model, announced that its Board of Directors has approved a… |
| 29 Oct 2026 | Yahoo Finance |
Nexentis: MitoCareX Completes Initial AI-Powered Computational Screening Milestone with Boltz
MitoCareX considers preliminary, not yet experimentally validated, computational findings encouraging for further computational analysis and experimental investigation Ness Ziona, Israel, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (NASDAQ: NXTS) (“Nexentis” or the “Company”)… |
| 26 Oct 2026 | Yahoo Finance |
Nexentis: MitoCareX Bio Advances AI-Driven Drug Discovery Initiative with Boltz, Completing Initial Computational Screening Stage
MitoCareX considers preliminary, not yet experimentally validated, computational findings encouraging for further computational analysis and experimental investigation Ness Ziona, Israel, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (NASDAQ: NXTS) (“Nexentis” or the “Company”) today… |
| 12 Oct 2026 | Yahoo Finance |
Nexentis: MitoCareX Bio Expands Computational Biology Capabilities to Advance Disease-Pathway Analysis
MitoCareX expands its internal bioinformatics expertise to broaden the analysis of disease biology within its computational drug-discovery activities Ness Ziona, Israel, Oct. 12, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (NASDAQ: NXTS) (“Nexentis” or the “Company”), today announced that… |
| 07 Oct 2026 | Yahoo Finance |
Nexentis Deploys MitoCareX Computational Drug Discovery Infrastructure on Google Cloud
Nexentis subsidiary MitoCareX has moved its computational drug discovery infrastructure to Google Cloud Platform, aiming to improve computing flexibility, scientific data management and research workflows as its discovery programs develop. Key Investor TakeawaysNexentis Technologies (NASDAQ:NXTS)… |
| 07 Oct 2026 | Yahoo Finance |
Nexentis: MitoCareX Bio Deploys its Computational Drug Discovery Infrastructure on Google Cloud
Deployment on Google Cloud Platform is designed to enhance computational capacity, data governance and operational flexibility as MitoCareX advances its drug discovery programs Ness Ziona, Israel, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (“Nexentis”), (NASDAQ: NXTS) (“Nexentis”… |
| 24 Sep 2026 | Yahoo Finance |
Nexentis: MitoCareX Strengthens Its Computational Drug Discovery Capabilities with Appointment of Prof. Dan T. Major to Scientific Advisory Board
Leading computational chemistry expert to advise MitoCareX as it expands its in silico drug-discovery capabilities Ness Ziona, Israel, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (“Nexentis”), (NASDAQ: NXTS) (“Nexentis” or the “Company”), a drug discovery company that also invests… |
| 23 Sep 2026 | Yahoo Finance |
Nexentis: MitoCareX Evaluates Expanded Protein Capabilities to Enhance Flexibility and Support Future Drug Discovery
Evaluation of additional commercially available approaches for obtaining proteins is intended to enhance access to research materials, increase research flexibility and support the advancement of MitoCareX’s future in-vitro drug discovery programs Ness Ziona, Israel, Sept. 23, 2026 (GLOBE NEWSWIRE)… |
Persediaan Teknikal Sederhana
AI Analisis Teknikal
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |